A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

Authors:	Yellin Michael Paliienko Igor Balanescu Andra Ter-Vartanian Semen Tseluyko Vira Xu Li-An Tao Xiaolu Cardarelli Pina M Leblanc Heidi Nichol Geoff Ancuta Codrina Chirieac Rodica Luo Allison

Affiliation:	Medarex, Bloomsbury, NJ, USA.

Abstract:

Keywords:
本文献已被 PubMed 等数据库收录！